Recurrent Hyperhemolysis Syndrome in Sickle Cell Disease

Area of Science:

• Hematology
• Immunology
• Transfusion Medicine

Background:

• Sickle cell disease (SCD) is a genetic blood disorder characterized by abnormal hemoglobin S.
• Hemoglobin S causes red blood cells to sickle, leading to vaso-occlusion and acute painful crises.
• Packed red blood cell transfusions are a common treatment for SCD complications, aiming to replenish functional hemoglobin.

Observation:

• Alloantibodies and autoantibodies can develop against transfused red blood cells.
• This immune response can trigger hyperhemolysis syndrome (HHS), a rare but severe transfusion complication.
• HHS presents significant challenges in managing acute episodes and sourcing compatible blood products.

Findings:

• This report details a case of recurrent hyperhemolysis syndrome in a sickle cell disease patient.
• Both episodes of HHS occurred post-orthopedic procedures.
• The recurrent HHS episode was refractory to multiple treatment modalities.

Implications:

• Recurrent HHS poses a substantial clinical challenge, complicating future transfusion management in SCD patients.
• The refractory nature of the recurrent episode highlights the need for novel therapeutic strategies.
• Understanding HHS pathogenesis is crucial for developing better diagnostic and treatment approaches for SCD patients requiring transfusions.